Brown Advisory’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.4M | Sell |
25,505
-355
| -1% | -$61.3K | 0.01% | 523 |
|
|
2025
Q1 | $4.03M | Sell |
25,860
-10,426
| -29% | -$1.62M | 0.01% | 524 |
|
|
2024
Q4 | $5M | Sell |
36,286
-431,366
| -92% | -$59.4M | 0.01% | 522 |
|
|
2024
Q3 | $69.8M | Sell |
467,652
-11,024
| -2% | -$1.65M | 0.09% | 170 |
|
|
2024
Q2 | $65.3M | Sell |
478,676
-205,396
| -30% | -$28M | 0.09% | 175 |
|
|
2024
Q1 | $103M | Buy |
684,072
+178,125
| +35% | +$26.9M | 0.14% | 129 |
|
|
2023
Q4 | $63.7M | Sell |
505,947
-4,162
| -0.8% | -$524K | 0.09% | 165 |
|
|
2023
Q3 | $47.8M | Buy |
510,109
+13,227
| +3% | +$1.24M | 0.08% | 195 |
|
|
2023
Q2 | $44.3M | Buy |
496,882
+30,510
| +7% | +$2.72M | 0.07% | 208 |
|
|
2023
Q1 | $50M | Buy |
466,372
+26,080
| +6% | +$2.8M | 0.08% | 191 |
|
|
2022
Q4 | $53.8M | Sell |
440,292
-197,709
| -31% | -$24.1M | 0.1% | 175 |
|
|
2022
Q3 | $65.9M | Sell |
638,001
-14,723
| -2% | -$1.52M | 0.13% | 144 |
|
|
2022
Q2 | $60.7M | Buy |
652,724
+133,112
| +26% | +$12.4M | 0.11% | 155 |
|
|
2022
Q1 | $61M | Buy |
519,612
+43,458
| +9% | +$5.1M | 0.09% | 176 |
|
|
2021
Q4 | $64.1M | Buy |
476,154
+54,927
| +13% | +$7.39M | 0.08% | 184 |
|
|
2021
Q3 | $67.1M | Buy |
421,227
+8,816
| +2% | +$1.41M | 0.1% | 163 |
|
|
2021
Q2 | $54.3M | Buy |
412,411
+109,989
| +36% | +$14.5M | 0.08% | 187 |
|
|
2021
Q1 | $39M | Buy |
302,422
+255,728
| +548% | +$33M | 0.07% | 212 |
|
|
2020
Q4 | $7.79M | Buy |
46,694
+8,253
| +21% | +$1.38M | 0.01% | 373 |
|
|
2020
Q3 | $5.93M | Buy |
38,441
+15,001
| +64% | +$2.32M | 0.01% | 383 |
|
|
2020
Q2 | $3.47M | Buy |
+23,440
| New | +$3.47M | 0.01% | 432 |
|
|
2019
Q2 | – | Sell |
-6,215
| Closed | -$732K | – | 1038 |
|
|
2019
Q1 | $732K | Buy |
+6,215
| New | +$732K | ﹤0.01% | 887 |
|